Kalaris Therapeutics Inc
KLRSHealthcare|Biotechnology|US
$2.42
+0.06 (+2.54%)
DCF Value
$6.25
Tangible Book / Share
$2.42
Cash / Share
$3.93
Clinical Trials (0)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|